BioCentury
ARTICLE | Clinical News

Toraymyxin: Ph III EUPHRATES data

January 6, 2017 10:32 PM UTC

Last October, Spectral reported top-line data from the double-blind, North American Phase III EUPHRATES trial in 450 patients with endotoxemic septic shock showing that 2 columns of Toraymyxin plus st...

BCIQ Company Profiles

Spectral Medical Inc.